Back to results
US 11,297,869 B2Granted
Botanical modulator of metabolic disorders
AssigneeInnophos, Inc.
InventorsJatinder Rana, Kylie Mitchell
Life of this patent
Estimating the term…
Abstract
Plant-based inhibitors of MMP-9 that also function as PPAR-γ agonists, and the use of such plant-based inhibitors/agonists in modulating metabolic disorders is disclosed. The plant-based inhibitor/agonist is at least an extract obtained from the genus Anacardium.
Claims5
A method of modulating one or more metabolic disorders in a subject comprising:
- administering a composition comprising a botanical extract of the testa of Anacardium occidentale L.,
- wherein the botanical extract has been standardized to a catechin content of about 15.0 w/w % or greater, based on total weight of the extract, and
- wherein the botanical extract is present in the composition in an amount of from about 15.0 μg/mL to about 250.0 μg/mL.
Dependencies are inferred from the claim text.